March 21, 2022 Recommendations to Optimize the Use of Volumetric MRI in Huntington’s Disease in Clinical Trials C-Path’s Huntington’s Disease Regulatory Science Consortium (HD-RSC) has published a new paper on volumetric MRI-based biomark
March 21, 2022 Recommendations to Optimize the Use of Volumetric MRI in Huntington’s Disease in Clinical Trials
March 18, 2022 Movement Disorders Congress 2021 | Presentations on behalf of CPP Critical Path for Parkinson’s members, advisors and staff submitted six posters on behalf of CPP and CPP’s digital effort, Dig
March 18, 2022 Metadata Framework to Support Deployment of Digital Health Technologies in Clinical Trials in Parkinson’s Disease Sensor data from digital health technologies (DHTs) used in clinical trials provides a valuable source of information...
March 16, 2022 View Now | AI-powered Real-world Simulations for Faster and Value-based Rare Disease Drug Development On March 16 Quinten Health CEO Billy Amzal, PhD, MBA, presented AI-powered Real-world Simulations for Faster and Value-base
March 11, 2022 Leveraging Real-World Data for EMA Qualification of a Model-Based Biomarker Tool to Optimize Type-1 Diabetes Prevention Studies The development of therapies to prevent or delay the onset of type 1 diabetes (T1D) remains challenging, and there is a lack of qu
March 7, 2022 eTRANSAFE: Building a sustainable framework to share reproducible drug safety knowledge with the public domain
March 2, 2022 Measurement Comparability of Electronic and Paper Administration of Visual Analogue Scales: A Review of Published Studies
February 23, 2022 Recommendations to Optimize the Use of Volumetric MRI in Huntington’s Disease in Clinical Trials C-Path’s Huntington’s Disease Regulatory Science Consortium (HD-RSC) has published a new paper on volumetric MRI-based....
February 6, 2022 View Now: Critical Path to Women Leading in Science Date: Feb 6, 2022 | 1:30 PM Eastern Time (US and Canada) Please join C-Path for a 90-minute roundtable discussing the Critical Pat
